Health Trials

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

ConditionsCardiovascular Diseases (CVD)Type 2 DiabetesChronic Respiratory DiseasesObesity (Disorder)Chronic Kidney Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-69
SponsorAsfendiyarov Kazakh National Medical University

About this trial

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Eligibility criteria

Qualifiers

Adults aged 18 to 69 years.

Residents of 17 regions of Kazakhstan.

Willingness to participate and provide informed consent.

Disqualifiers

Age less than 18 years old or over 69 years old.

Failure to provide informed consent or incomplete participation in data collection procedures.

Trial design

Treatments tested in this trial

  • Genetic: DNA analysis

Treatment groups

6,720 Participants
are divided into 1 treatment group

Sponsors and collaborators

Asfendiyarov Kazakh National Medical University

Lead sponsor

Source ClinicalTrials.gov